Thus, this study was designed to prospectively analyze a cohort of lung cancer patients receiving immunotherapy and to attempt to determine cellular biomarkers in peripheral blood that are predictive of response, focusing on some of the main cells involved in cancer immunity and response to immunotherapy, namely, CD4+ and CD8+T, and NK cell subsets. This evidence concerns the gene CD8A and cancer.